In vitro downregulation of Gsn in breast cancer MDA-MB 231 and in prostate cancer PC-3 cell lines reduced the cells' invasive and motile properties, as well as cell aggregation (Van den Abbeele et al., 2007). The gene discussed is GSN; the disease is prostate carcinoma.